Accuro Epidural Guidance Device Demonstrated Superior for Spinal Anesthesia Administration Compared to Palpation & Conventional Ultrasound in a Parturient With Extreme Obesity
16. August 2022 06:00 ET
|
RIVANNA (rivannamedical.com)
CHARLOTTESVILLE, Va., Aug. 16, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, announced the results of a clinical case study demonstrating that Accuro...
RIVANNA® Appoints Medical Technology Veteran Nikki Troiano Gainey to Board of Directors
07. Juli 2022 06:00 ET
|
RIVANNA (rivannamedical.com)
CHARLOTTESVILLE, Va., July 07, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, has named Nikki Troiano Gainey, a MedTech corporate and marketing...
RIVANNA® Expands World-Class Engineering Team to Advance Development of the Accuro® Product Platform
18. Januar 2022 06:00 ET
|
Rivanna Medical
CHARLOTTESVILLE, Va., Jan. 18, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the appointment of Paul Sheeran, Ph.D., as senior...
RIVANNA Purchases New Facility Signaling Rapid Growth
09. November 2021 06:00 ET
|
Rivanna Medical
CHARLOTTESVILLE, Va., Nov. 09, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the purchase of a 10,000 square-foot facility in...
RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia
27. September 2021 06:00 ET
|
Rivanna Medical
CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial...
RIVANNA's Accuro Automatically Identifies and Measures Epidural Space Depth With Accuracy Equivalent to Standard Ultrasound in Obese Pregnant Women
13. September 2021 06:00 ET
|
Rivanna Medical
CHARLOTTESVILLE, Va., Sept. 13, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a prospective, double-blind study...